Law.com Subscribers SAVE 30%

Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.

Search

We found 1,278 results for "Medical Malpractice Law & Strategy"...

Movers & Shakers
March 29, 2010
Who's doing what; who's going where.
Verdicts
March 29, 2010
Recent rulings of importance to you and your practice.
Drug & Device News
March 29, 2010
Recent news you need to know.
Med Mal News
March 29, 2010
A roundup of recent news important to your practice.
Jury Awards $25.16 Million on Claim Acne Drug Caused Bowel Illness
March 29, 2010
An Atlantic County jury awarded $25.16 million to a Birmingham, AL, man after finding that Roche Laboratories Inc. knew or should have known that Accutane caused inflammatory bowel disease (IBD) and failed to warn prescribing physicians.
Dissecting the Latest Pronouncements on Ex parte Physician Interviews
March 29, 2010
There is a recurring battle playing out in trial courts across the country in medical negligence cases as to whether <i>ex parte</i> interviews with a patient's treating physicians are permissible under HIPAA and its implementing privacy rules.
The Battle of Experts
March 29, 2010
The first installment of this article discussed how facts and opinions are not the only things a jury considers in deciding the outcome of a medical malpractice case; jurors also pay close attention to large and small gaffes that may show an expert is biased. How can you best exploit these lapses when showing that the other side's experts are less reliable than they might appear?
Movers & Shakers
February 25, 2010
Who's doing what; who's going where.
Verdicts
February 25, 2010
Recent rulings of importance to you and your practice.
Drug & Device News
February 25, 2010
The latest important news.

MOST POPULAR STORIES

  • Private Equity Valuation: A Significant Decision
    Insiders (and others) in the private equity business are accustomed to seeing a good deal of discussion ' academic and trade ' on the question of the appropriate methods of valuing private equity positions and securities which are otherwise illiquid. An interesting recent decision in the Southern District has been brought to our attention. The case is <i>In Re Allied Capital Corp.</i>, CCH Fed. SEC L. Rep. 92411 (US DC, S.D.N.Y., Apr. 25, 2003). Judge Lynch's decision is well written, the Judge reviewing a motion to dismiss by a business development company, Allied Capital, against a strike suit claiming that Allied's method of valuing its portfolio failed adequately to account for i) conditions at the companies themselves and ii) market conditions. The complaint appears to be, as is often the case, slap dash, content to point out that Allied revalued some of its positions, marking them down for a variety of reasons, and the stock price went down - all this, in the view of plaintiff's counsel, amounting to violations of Rule 10b-5.
    Read More ›
  • Meet the Lawyer Working on Inclusion Rider Language
    At the Oscars in March, Best Actress winner Frances McDormand made “inclusion rider” go viral. But Kalpana Kotagal, a partner at Cohen Milstein Sellers &amp; Toll had already worked for months to write the language for such provisions. Kotagal was developing legal language for contract provisions that Hollywood's elite could use to require studios and other partners to employ diverse workers on set.
    Read More ›